Alkem Laboratories (India) Price Prediction and Hype Density Breakdown

ALKEM -- India Stock  

INR 1,942  0.35  0.018%

We analyze noise-free headlines and recent hype associated with Alkem Laboratories Limited which may create opportunities for some arbitrage if properly timed. With Alkem Laboratories hype-based prediction module you can estimate the value of Alkem Laboratories Limited from the prospective of Alkem Laboratories response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Alkem Laboratories over a specific investment horizon. Check also Trending Equities.
Horizon     30 Days    Login   to change

Alkem Laboratories After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Alkem Laboratories Estimiated After-Hype Price Volatility

November 20, 2018
Current Value
After-hype Price
Target Odds
Alkem Laboratories is Unknown risk asset. Analysis and calculation of next after-hype price of Alkem Laboratories is based on 1 month time horizon.

Alkem Laboratories Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.03% 1.18% 0.55%  0.39% 2 Events / Month3 Events / MonthIn a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Alkem Laboratories Hype Timeline

Alkem Laboratories Limited is presently traded for 1,942on Bombay Stock Exchange of India. This company has historical hype elasticity of 0.55 and average elasticity to hype of competition of -0.39. Alkem Laboratories Limited is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 6.45%. The immediate return on the next news is anticipated to be very small where as daily expected return is presently at -0.03%. The volatility of relative hype elasticity to Alkem Laboratories is about 9.13%%. The volatility of related hype on Alkem Laboratories is about 9.13% with expected price after next announcement by competition of 1941.91. The book value of the company was presently reported as 436.94. The company has Price/Earnings To Growth (PEG) ratio of 0.21. Alkem Laboratories Limited recorded earning per share (EPS) of 52.64. This company last dividend was issued on 2018-08-23. Assuming 30 trading days horizon, the next anticipated press release will be in a few days.
Check also Trending Equities.

Alkem Laboratories Related Hype Analysis

At Risk
Lupin Limited 2.45 5 per month 1.76  0.08  3.13 (3.00)  8.29 
Glenmark Pharmaceuticals Limited(0.15) 4 per month 1.56  0.19  3.38 (2.60)  7.14 
Merck Limited(28.95) 2 per month 2.75  0.12  5.00 (4.58)  11.81 
Merck Limited(114.55) 2 per month 3.53  0.06  6.87 (5.33)  16.74 
Strides Shasun Limited 0.00 0 per month 2.13  0.13  5.37 (3.60)  14.25 
Shilpa Medicare Limited(5.15) 1 per month 0.00 (0.07)  2.30 (3.54)  6.42 
Suven Life Sciences Limited 15.65 1 per month 0.00 (0.05)  4.23 (7.68)  13.65 
Suven Life Sciences Limited 3.00 1 per month 2.82  0.08  5.85 (3.94)  15.43 
Indoco Remedies Limited(1.05) 1 per month 0.00 (0.08)  4.87 (4.79)  15.14 
Alembic Limited(0.55) 1 per month 0.00  0.13  4.19 (2.71)  11.04 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 300 shares
Active few hours ago
Purchased a lot of shares
Active few hours ago
Purchased over 20 shares
Active few hours ago
Purchased over 90 shares
Active few hours ago
Purchased over 20 shares
Active few hours ago
Purchased over 70 shares
Active few hours ago
Purchased few shares
Active few hours ago
Purchased over 10K shares
Active a day ago
Purchased over 400 shares
Active a day ago
Purchased over 300 shares
Active a day ago
Purchased over 20 shares
Active a day ago
Check also Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.